Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 6 (2009), Issue 12 (December)

1. Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine.
   J Nucl Med, 50(12): 2008-16. [Abstract] [Full-text]
2. Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis.
   J Nucl Med, 50(12): 2033-41. [Abstract] [Full-text]
3. Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report.
   Neurology, 73(22): 1906-13. [Abstract] [Full-text]
4. Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique.
   Neurosurg Focus, 27(6): E9. [Abstract] [Full-text]
5. Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme.
   Neurosurg Focus, 27(6): E8. [Abstract] [Full-text]
6. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
   Neurosurg Focus, 27(6): E7. [Abstract] [Full-text]
7. Control of brain metastases using frameless image-guided radiosurgery.
   Neurosurg Focus, 27(6): E6. [Abstract] [Full-text]
8. Radiosurgery for glomus jugulare: history and recent progress.
   Neurosurg Focus, 27(6): E5. [Abstract] [Full-text]
9. Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma.
   Neurosurg Focus, 27(6): E4. [Abstract] [Full-text]
10. Evaluation of hearing function after Gamma Knife surgery of vestibular schwannomas.
    Neurosurg Focus, 27(6): E3. [Abstract] [Full-text]
11. Emerging applications of stereotactic radiotherapy in head and neck cancer.
    Neurosurg Focus, 27(6): E11. [Abstract] [Full-text]
12. Stereotactic spine radiosurgery for intradural and intramedullary metastasis.
    Neurosurg Focus, 27(6): E10. [Abstract] [Full-text]
13. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.
    J Neurosurg Pediatr, 4(6): 506-14. [Abstract] [Full-text]
14. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    J Med Chem, 52(23): 7829-35. [Abstract] [Full-text]
15. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    Am J Clin Oncol, 32(6): 587-91. [Abstract] [Full-text]
16. Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence.
    J Clin Oncol, 27(35): 6000-5. [Abstract] [Full-text]
17. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.
    N Engl J Med, 361(24): 2309-17. [Abstract] [Full-text]
18. A murine model for the study of molecular pathogenesis of radiation proctitis.
    Int J Radiat Oncol Biol Phys, 76(1): 242-50. [Abstract] [Full-text]
19. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience.
    Int J Radiat Oncol Biol Phys, 76(1): 50-6. [Abstract] [Full-text]
20. Bone regeneration in defects compromised by radiotherapy.
    J Dent Res, 89(1): 77-81. [Abstract] [Full-text]
21. Hypofractionation: what does it mean for prostate cancer treatment?
    Int J Radiat Oncol Biol Phys, 76(1): 260-8. [Abstract] [Full-text]
22. Feasibility of single-isocenter volumetric modulated arc radiosurgery for treatment of multiple brain metastases.
    Int J Radiat Oncol Biol Phys, 76(1): 296-302. [Abstract] [Full-text]
23. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
    Int J Radiat Oncol Biol Phys, 76(1): 269-76. [Abstract] [Full-text]
24. Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes.
    Int J Radiat Oncol Biol Phys, 76(1): 287-95. [Abstract] [Full-text]
25. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys, 76(1): 138-45. [Abstract] [Full-text]
26. Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society.
    Int J Radiat Oncol Biol Phys, 76(1): 104-9. [Abstract] [Full-text]
27. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
    Int J Radiat Oncol Biol Phys, 76(1): 193-200. [Abstract] [Full-text]
28. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.
    Int J Radiat Oncol Biol Phys, 76(1): 14-22. [Abstract] [Full-text]
29. Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis.
    Int J Radiat Oncol Biol Phys, 76(1): 43-9. [Abstract] [Full-text]
30. Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice.
    Int J Radiat Oncol Biol Phys, 76(1): 146-53. [Abstract] [Full-text]
31. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation.
    Int J Radiat Oncol Biol Phys, 76(1): 71-8. [Abstract] [Full-text]
32. Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost.
    Int J Radiat Oncol Biol Phys, 76(1): 36-42. [Abstract] [Full-text]
33. Radiation therapy alone for imaging-defined meningiomas.
    Int J Radiat Oncol Biol Phys, 76(1): 181-6. [Abstract] [Full-text]
34. Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys, 76(1): 57-64. [Abstract] [Full-text]
35. Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation.
    Int J Radiat Oncol Biol Phys, 76(1): 91-9. [Abstract] [Full-text]
36. Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer.
    Int J Radiat Oncol Biol Phys, 76(1): 164-8. [Abstract] [Full-text]
37. Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy.
    Int J Radiat Oncol Biol Phys, 76(1): 187-92. [Abstract] [Full-text]
38. First results of the federal quality assurance group ("Arztliche Stelle") in radiotherapy in Baden-Württemberg: part 2.
    Strahlenther Onkol, 185(12): 830-6. [Abstract] [Full-text]
39. Overestimation of low-dose radiation in intensity-modulated radiotherapy with sliding-window technique.
    Strahlenther Onkol, 185(12): 821-9. [Abstract] [Full-text]
40. Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.
    Strahlenther Onkol, 185(12): 808-14. [Abstract] [Full-text]
41. Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation.
    Strahlenther Onkol, 185(12): 799-807. [Abstract] [Full-text]
42. Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children.
    Strahlenther Onkol, 185(12): 789-98. [Abstract] [Full-text]
43. Feasibility and early outcomes of supine-position craniospinal irradiation.
    Pediatr Blood Cancer, 54(2): 322-5. [Abstract] [Full-text]
44. Optimal margin and edge-enhanced intensity maps in the presence of motion and uncertainty.
    Phys Med Biol, 55(2): 515-33. [Abstract] [Full-text]
45. Hybrid plan verification for intensity-modulated radiation therapy (IMRT) using the 2D ionization chamber array I'mRT MatriXX--a feasibility study.
    Phys Med Biol, 55(2): N39-55. [Abstract] [Full-text]
46. A methodology for selecting the beam arrangement to reduce the intensity-modulated radiation therapy (IMRT) dose to the SPECT-defined functioning lung.
    Phys Med Biol, 55(2): 403-16. [Abstract] [Full-text]
47. Development of a frameless stereotactic radiosurgery system based on real-time 6D position monitoring and adaptive head motion compensation.
    Phys Med Biol, 55(2): 389-401. [Abstract] [Full-text]
48. A novel method for patient exit and entrance dose prediction based on water equivalent path length measured with an amorphous silicon electronic portal imaging device.
    Phys Med Biol, 55(2): 435-52. [Abstract] [Full-text]
49. Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
    Radiology, 254(1): 245-52. [Abstract] [Full-text]
50. Hyperbaric oxygen therapy for radiation-induced brain necrosis in a patient with primary central nervous system lymphoma.
    J Surg Oncol, 100(8): 732-5. [Abstract] [Full-text]
51. Controversies concerning the application of brachytherapy in central nervous system tumors.
    J Cancer Res Clin Oncol, 136(2): 173-85. [Abstract] [Full-text]
52. CT guidance is needed to achieve reproducible positioning of the mouse head for repeat precision cranial irradiation.
    Radiat Res, 173(1): 119-23. [Abstract] [Full-text]

© 2004-2012 Radiotherapy Research Today. All Rights Reserved.